Aurora Cannabis Inc. (ACB)

9.47
0.34 3.50
NYSE : Health Technology
Prev Close 9.81
Day Low/High 9.54 / 9.87
52 Wk Low/High 4.00 / 12.53
Avg Volume 28.51M
Exchange NYSE
Shares Outstanding 1.01B
Market Cap 10.06B
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results

Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results

Tilray shares turn following the company's fourth-quarter results while other pot stocks trade mixed.

With Tilray, You Won't Win Any Valuation Arguments

With Tilray, You Won't Win Any Valuation Arguments

Short interest is back in the low single digits while Tilray still enjoys one of the smallest floats for a cannabis company.

Trading Tilray Stock's Wild Post-Earnings Volatility

Trading Tilray Stock's Wild Post-Earnings Volatility

Tilray's wide trading range on Tuesday is relatively calm considering the important levels it's teetering on.

Tilray Is Not My Favorite Canadian Cannabis Stock

Tilray Is Not My Favorite Canadian Cannabis Stock

Apparently, this game is all about growth right now. It certainly is not about margins.

Stocks Under $10 Weekly Summary

Last week was a very good one for the portfolio as nine of our 13 holdings outperformed our benchmark, the Russell 2000.

Here's How Tilray Is Doing Ahead of Monday's Earnings Release

Here's How Tilray Is Doing Ahead of Monday's Earnings Release

Tilray is expected to increase its revenue by more than 50% from the previous quarter.

Look Out for an Intraday Reversal in the Market

Look Out for an Intraday Reversal in the Market

Some momentum movers are becoming extended and have seen profit-taking Monday.

Don't Miss Out on the Trading Action

Don't Miss Out on the Trading Action

If you dig a little deeper there is some very positive action.

Chart of the Day: Vetting the Value of Cannabis Companies

Chart of the Day: Vetting the Value of Cannabis Companies

Assessing Aurora and its peers, strictly on the numbers.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Stocks End Higher, Shrugging Off Brexit and Boeing Concerns

Stocks End Higher, Shrugging Off Brexit and Boeing Concerns

Stocks ended higher Wednesday as Wall Street looks past uncertainty about Brexit and worries about Boeing after the United States became the latest country to ground the 737 Max 8.

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz's addition should pacify a persistent critique of the company.

S&P 500 Strength: One Glaring Statistic Makes U.S. Stocks Attractive

S&P 500 Strength: One Glaring Statistic Makes U.S. Stocks Attractive

When you're done gawking at the S&P, Aurora Cannabis rose 12% Wednesday, but may have even more juice left in it short-term

Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

Aurora Cannabis Spikes After Billionaire Activist Nelson Peltz Added as Adviser

Aurora Cannabis Spikes After Billionaire Activist Nelson Peltz Added as Adviser

Aurora Cannabis shares were indicated sharply higher Wednesday after it named billionaire activist investor Nelson Peltz as a strategic adviser to the Canada-based group.

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Nelson Peltz Could Be Key to Cannabis in Consumer Packaged Goods

Aurora's prominent partner could be cannabis' key to breaking into consumer segments.

Aurora Cannabis Builds Momentum, Enter Nelson Peltz

Aurora Cannabis Builds Momentum, Enter Nelson Peltz

The plan is for Peltz to help the firm in maximizing potential markets to target.

It's Who Puts Money Into Cannabis Companies That Matters: Jim Cramer

It's Who Puts Money Into Cannabis Companies That Matters: Jim Cramer

Nelson Peltz may be making Aurora relevant in today's headlines, but it's who invests money in the companies that counts, according to Jim Cramer.

Why Jim Cramer Likes Nelson Peltz's Addition to Aurora, and Big Tech

Why Jim Cramer Likes Nelson Peltz's Addition to Aurora, and Big Tech

Jim Cramer's got some thoughts on cannabis and whether or not it's time to break up big tech.

Ringing the Register on Some of a Surging Position

We will trim part of our Pareteum holdings as the stock has surpassed our price target.

This Cannabis Stock Is Smokin' Today

Aurora Cannabis is now on five continents and doing it all.

Aurora Cannabis, Nelson Peltz, and the Move For Acquisitions

Aurora Cannabis, Nelson Peltz, and the Move For Acquisitions

Themes like cannabis tend to persist longer than many think they will.

Good Times for These Two Positions

We are riding high with both Pareteum and Aurora Cannabis.

Aurora Cannabis Could Triple in the Months Ahead

Aurora Cannabis Could Triple in the Months Ahead

The price of ACB is moving up today and a fresh look at the charts and indicators seems like a good idea.

Jim Cramer's Thoughts on Aurora Cannabis and Breaking Up Big Tech

Jim Cramer's Thoughts on Aurora Cannabis and Breaking Up Big Tech

Wondering what's moving these markets? Here's what Jim Cramer thinks about Aurora Cannabis adding Nelson Peltz as an advisor and the proposals to break up big tech.

Aurora Cannabis Stock Burns Higher After Adding Billionaire Advisor Peltz

Aurora Cannabis Stock Burns Higher After Adding Billionaire Advisor Peltz

Aurora's addition of a big name activist is accelerating share growth.

Aurora Cannabis Appoints Nelson Peltz As Strategic Advisor

Aurora Cannabis Appoints Nelson Peltz As Strategic Advisor

NYSE| TSX: ACB EDMONTON and NEW YORK, March 13, 2019 /PRNewswire/ - Aurora Cannabis Inc.

TheStreet Quant Rating: D+ (Sell)